It is our hope that this issue of American Journal of Health Promotion will promote further discussions on health promotion among policy makers, businesses, health care providers, and researchers in Japan and worldwide. In exploring strategies for sustainable delivery of comprehensive quality health services, it is critical that discussions be based on data-driven empirical research. We would like to avoid premature rejection of health promotion, created by its careless introduction and lack of solid evaluation, in Japan or any other nation in the world. Careless introduction of a new innovation fails even if the innovation may have great potential.
International dissemination is especially challenging because of the need to pay attention to many societal and cultural differences. Dissemination of health promotion is no exception. International collaboration in health promotion is already occurring through institutional cooperation as well as personal exchange. This collaboration is very encouraging, but it is critical to examine the external validity of research findings when disseminating findings across nations and cultures. Health promotion research in the United States has compiled substantial evidence that provides rationales for health promotion, especially in the workplace setting. It is hard to disagree with the idea of promoting health, preventing disease, and maintaining and enhancing the health of people. However, issues arise when it comes to making decisions as to who would pay for health promotion, how it is implemented, and how the outcomes are defined and evaluated. Vigorous effort has been spent on dealing with such issues in the United States. Because growing evidence shows that lifestyle factors account for a large portion of premature deaths and medical costs, legislation is beginning to emerge to make health promotion an important part of national health policy in the United States. 1 Still, it is important to stress that what works in the United States may not necessarily work in Japan or other Japan is often seen as one of the healthiest nations in the world. This claim is supported by long life expectancy, low infant mortality rates, universal health coverage, and relatively low medical care costs as a portion of gross domestic product. 2 However, this apparently ideal situation may not last much longer. Japan has a rapidly aging population; older adults will be consuming more medical care and fewer workers will be available to cover their costs. 3 Because Japan's economy has had little growth in the 1990s, 4 the financial weaknesses in its systems are being exposed. Changes in the health care system are already occurring, and affordable universal health care coverage may be in jeopardy. For example, the individual copayment for services among employees increased from 10% to 20% in 1997 and to 30% in 2003. A new insurance scheme to finance elderly care also has begun to attempt to deal with one of the most pressing health care issues.
Among many strategies for the betterment of health care, health promotion has been receiving attention in Japan. However, discussions on health promotion in policy making as well as in business apparently have not been supported by solid data-driven research.
Healthy Japan 21, 5 a governmental initiative to prevent disease and promote health, has been criticized for the absence of practical plans for implementation and the lack of data-driven justification for feasible health objectives. In some areas there is little evidence that the proposals are feasible, and in other areas baseline data on risk factors are missing. Some objectives were set based on moral idealism.
Many for-profit corporations have quickly become health promotion providers selling U.S. health promotion products to Japanese employers. These corporations tend to offer ungrounded promises of medical care cost savings by quoting findings in other countries, mostly in the United States.
Lack of data-driven evidence is not limited to health promotion. Evaluation has not been strong in the entire health care system in Japan even though evidence-based medicine already has become a buzzword. We should wonder why the health care system used to afford not engaging in evaluation.
In the United States, managed health care providers share financial risk for delivering health care services; therefore, they are motivated to scrutinize their services for their costs and health outcomes. Furthermore, the incentive for providers to keep patients healthy has risen. However, Japan's health care system is based on a fee-forservice reimbursement system with the guarantee of access to any physicians. Reimbursement is made primarily for the care of disease, whereas prevention is rarely covered. Therefore, each provider does not have any ''defined patient population'' to keep healthy. Also, health insurers have little competitive motivation to improve their data-management capabilities because of a standardized, government-regulated reimbursement system that provides little freedom to innovate. Additionally, technical challenges exist in the health information infrastructure in Japan that make engaging in health service evaluation difficult. In health promotion research, it is important to examine data on the full spectrum of the health-illness continuum. Unfortunately, no single entity in Japan has such data. Annual physical checkups that are administered by employers according to the Occupational Health and Safety Law collect health risk data. Such data are usually held by employers, but data on use of medical services by employees are held by each employer's health insurance society. There is a legally mandated separation of the insurance society from its corresponding employer. Therefore, it has been challenging to examine the relationships between health risk and medical care because such effort requires merging both datasets.
Fortunately, that technical challenge has been overcome by one major corporation in Japan that wishes to remain anonymous but has agreed to provide its employees' data on health risk and medical care claims for research purposes. Through the third party's involvement in scrambling the identification information to ensure employee privacy, a database that integrates health risk and medical care claims on an individual basis was created for analysis.
With this background in mind, we would like to briefly review the contents of this special issue.
The issue begins with a comprehensive review of U.S. experiences in worksite health promotion by Pelletier. 6 He discusses the evidence for clinical effectiveness and Return on Investment (ROI) of comprehensive, multifactorial risk and disease management in the worksite setting. This extensive overview will help readers, especially in Japan, become familiar with the vigorous endeavors in health promotion in the United States.
Lynch et al., 7 using the aforementioned health and disease data of employees in Japan, applied methods of analysis that have been used in the United States in examining the association between risk and medical care costs. Through their demonstration of ''U.S. standard'' analytical techniques, they found mixed results; some techniques are in the same direction as those found in the United States, but unexpected associations were also found. The authors suggest more reliable and valid risk assessments be conducted in Japan.
We have included an examination on associations between dental costs and lifestyle risk factors, for dental care accounts for a quarter of medical costs among employers in Japan. 8 Interestingly, Chikamoto et al. 8 found that smoking was associated with dental costs but not medical costs. They suspect a time lag between the presence of risk factors and medical costs, but the effect is more immediate between risk factors and dental costs.
With the same risk and disease database, Nishimura et al. 9 used an insightful technique of analysis that controls for the presence or absence of diagnosis. First, they found an alarmingly large proportion of employees who were identified as having high risk for lifestyle diseases yet who had not seen physicians for that concern. This finding highlights an issue resulting from Japan's current health care system where providers who administer physical checkups are different from those who provide follow-up clinical services. On the basis of the findings that increased medical care costs were associated not with risk only but with diagnosis (i.e., seeing physicians for the concern), the authors project increase in medical care costs, at least in the short term, once the employers start providing health promotion programs.
In addition to the aforementioned data-driven research, we believe that this special issue focusing on Japan would not be complete without discussing issues on tobacco, the single most preventable cause of death. The Japanese government's hesitation in tobacco control and relatively high smoking rates among Japanese men were often discussed in the international health community.
In the interview conducted by Hwang, 10 Dr. John Farquhar, one of the pioneers in cardiovascular risk reduction, reflects on the history of the tobacco-control movement in the United States. Active involvement of health professionals in education and advocacy has been highlighted.
Asukai et al. 11 provide an overview of recently emerging antitobacco movements in Japan. However, they caution that such movements not have been motivated or supported by health concerns.
The next step would be further research involving a multiemployer database with a larger number of employees, just like the Health Enhancement Research Organization has done. 12 In doing so, it is critical that a consensus on reliable and valid measures of health risk be reached. The existing standardized payment schedule for medical care services combined with the standardized risk measures would provide excellent research opportunities. The development of a national database may not be too far from reality. In such an effort, it is essential that researchers pay more careful attention to the details of medical care patterns rather than use total medical care costs as an indicator of medical care.
Furthermore, longitudinal research designs are needed, not only to examine the relationships between health risk and medical care costs, but also to identify the efficacy of health promotion interventions.
We hope that this special issue will provide a starting point for policy makers and businesses to examine health promotion based on empirical evidence, and will stimulate further scientific inquiry in international dissemination of health promotion.
